110 related articles for article (PubMed ID: 17586422)
1. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):243-9. PubMed ID: 17586422
[TBL] [Abstract][Full Text] [Related]
2. Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study.
Christensen JH; Aarøe J; Knudsen N; Dideriksen K; Kornerup HJ; Dyerberg J; Schmidt EB
Clin Nephrol; 1998 Feb; 49(2):102-6. PubMed ID: 9524780
[TBL] [Abstract][Full Text] [Related]
3. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
4. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
5. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
[TBL] [Abstract][Full Text] [Related]
6. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH;
Clin J Am Soc Nephrol; 2006 Jul; 1(4):780-6. PubMed ID: 17699287
[TBL] [Abstract][Full Text] [Related]
7. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[TBL] [Abstract][Full Text] [Related]
8. [n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial].
Christensen JH; Gustenhoff P; Korup E; Aarøe J; Toft E; Møller JM; Rasmussen K; Dyerberg J; Schmidt EB
Ugeskr Laeger; 1997 Sep; 159(37):5525-9. PubMed ID: 9312922
[TBL] [Abstract][Full Text] [Related]
9. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
Christensen JH
Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
[TBL] [Abstract][Full Text] [Related]
10. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
Begum R; Belury MA; Burgess JR; Peck LW
J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
[TBL] [Abstract][Full Text] [Related]
11. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
12. [Heart rate variability alteration in patients on chronic hemodialysis].
Salameh E; Mallat S; Hamdan R; Azar H; Azar R; Kadri Z; Kassab R; Abou Jaude S; Badaoui G
Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):7-10. PubMed ID: 18980756
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous omega-3 fatty acid infusion and hemodialysis on fatty acid composition of free fatty acids and phospholipids in patients with end-stage renal disease.
Madsen T; Christensen JH; Toft E; Aardestrup I; Lundbye-Christensen S; Schmidt EB
JPEN J Parenter Enteral Nutr; 2011 Jan; 35(1):97-106. PubMed ID: 21224436
[TBL] [Abstract][Full Text] [Related]
15. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction.
Grundt H; Nilsen DW; Mansoor MA; Nordøy A
Eur J Clin Nutr; 2003 Jun; 57(6):793-800. PubMed ID: 12792664
[TBL] [Abstract][Full Text] [Related]
16. Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients.
Kirkegaard E; Svensson M; Strandhave C; Schmidt EB; Jørgensen KA; Christensen JH
Br J Nutr; 2012 Mar; 107(6):903-9. PubMed ID: 21791142
[TBL] [Abstract][Full Text] [Related]
17. N-3 fatty acids and cardiac autonomic function in humans.
Christensen JH; Svensson M; Strandhave C; Madsen T; Schmidt EB
Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):131-9. PubMed ID: 20196976
[TBL] [Abstract][Full Text] [Related]
18. Alteration of heart rate variability parameters in nondiabetic hemodialysis patients.
Tong YQ; Hou HM
Am J Nephrol; 2007; 27(1):63-9. PubMed ID: 17259695
[TBL] [Abstract][Full Text] [Related]
19. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
Moreira AC; Gaspar A; Serra MA; Simões J; Lopes da Cruz J; Amaral TF
J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553
[TBL] [Abstract][Full Text] [Related]
20. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
